CapsoVision (CV) Net Cash Flow (2024 - 2025)
CapsoVision (CV) reported Net Cash Flow of -$7.7 million for Q4 2025, down 1829.4% on a YoY basis from $444027.6 in Q4 2024, and down 145.96% sequentially from $16.7 million in Q3 2025.
CapsoVision (CV) Net Cash Flow (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Net Cash Flow data on file, last reported at -$7.7 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow fell 1829.4% year-over-year to -$7.7 million; the trailing twelve-month figure through Dec 2025 stood at $8.6 million (changed N/A YoY), and the FY2025 full-year result was $650000.0, up 112.57% from the prior year.
- Net Cash Flow eased to -$7.7 million in Q4 2025, from $16.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $16.7 million in Q3 2025 to a low of -$7.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | -7.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.68 Mn |
| Dec 31, 2025 | -7.68 Mn |
| Sep 30, 2025 | 16.71 Mn |
| Sep 30, 2025 | 16.71 Mn |
| Dec 31, 2024 | -398,000.00 |
| Dec 31, 2024 | -398,000.00 |
| Sep 30, 2024 | 2.94 Mn |
| Sep 30, 2024 | 2.94 Mn |